Patents by Inventor Eric Jorgenson

Eric Jorgenson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Rare Variants In Hematopoietic Stem Cells (HSC) And Hematopoietic Progenitor Cells (HPC) Associated With Somatic Alterations Of The Blood
    Publication number: 20230383351
    Abstract: Methods of treating, preventing, or reducing somatic alterations of the blood of a subject with kinetochore associated 1 (KNTC1) antagonists, ring finger and CCCH-type domains 1 (RC3H1) agonists, YLP motif containing 1 (YLPM1) agonists, Major Histocompatibility Complex, Class II, and/or DR beta 5 (HLA-DRB5) agonists are provided herein. Methods of treating a subject with a therapeutic agent that treats, prevents, or reduces somatic alterations of the blood are also provided. Methods of identifying a subject having an increased risk of developing somatic alterations of the blood are also provided.
    Type: Application
    Filed: April 19, 2023
    Publication date: November 30, 2023
    Inventors: Michael D. Kessler, Hyun Min Kang, Eric Jorgenson
  • Association Of T Cell Leukemia/Lymphoma Protein 1A (TCL1A) With Clonal Hematopoiesis Of Indeterminate Potential (CHIP)
    Publication number: 20230340598
    Abstract: Methods of treating subjects having clonal hematopoiesis of indeterminate potential (CHIP) with T Cell Leukemia/Lymphoma Protein 1A (TCL1A) antagonists, and methods of identifying subjects having an increased or decreased risk of developing CHIP are provided herein.
    Type: Application
    Filed: October 31, 2022
    Publication date: October 26, 2023
    Inventors: Eric Jorgenson, Michael Kessler, Amy Damask, Sean O’Keeffe
  • Methods Of Treating Clonal Hematopoiesis Of Indeterminate Potential (CHIP) With Lymphocyte Antigen 75 (LY75), Cluster Of Differentiation 164 (CD164), Or Poly(ADP-Ribose) Polymerase 1 (PARP1) Inhibitors
    Publication number: 20230113866
    Abstract: Methods of treating subjects having clonal hematopoiesis of indeterminate potential (CHIP) with lymphocyte antigen 75 (LY75), Cluster of Differentiation 164 (CD164), or Poly(ADP-Ribose) Polymerase 1 (PARP1) inhibitors, and methods of identifying subjects having an increased risk of developing CHIP are provided herein.
    Type: Application
    Filed: September 12, 2022
    Publication date: April 13, 2023
    Inventors: Eric Jorgenson, Michael Kessler, Amy Damask, Sean O'Keeffe, Ryan White, David Glass
  • Methods Of Treating Skin Cancer With Carboxypeptidase Vitellogenic Like (CPVL) Inhibitors
    Publication number: 20230037524
    Abstract: The present disclosure provides methods of treating a subject having skin cancer or preventing a subject from developing skin cancer, and methods of identifying subjects having an increased risk of developing skin cancer.
    Type: Application
    Filed: July 5, 2022
    Publication date: February 9, 2023
    Inventors: Xinyuan Zhang, Julie Horowitz, Stefan Semrau, Goncalo Abecasis, Gavin Thurston, Eric Jorgenson, Aris Baras
  • Methods Of Treating Skin Cancer With Histidine Ammonia-Lyase (HAL) Agonists
    Publication number: 20230016750
    Abstract: The present disclosure provides methods of treating subjects having skin cancer or at risk of developing skin cancer, and methods of identifying subjects having an increased risk of developing skin cancer.
    Type: Application
    Filed: July 5, 2022
    Publication date: January 19, 2023
    Inventors: Manuel Allen Revez Ferreira, Joshua Backman, Alexander Li, Michael Kessler, Eric Jorgenson, Aris Baras, Goncalo Abecasis